Subscribe

0

Advertisment

Sickle Cell Disease

Regeneron Pharmaceuticals and Mammoth Biosciences to Collaborate on Gene Editing Therapies Business

Regeneron Pharmaceuticals and Mammoth Biosciences to Collaborate on Gene Editing Therapies

New York-based Regeneron Pharmaceuticals is partnering with Brisbane, California-based Mammoth Biosciences (founded by Doudna) to research, develop, and commercialize gene editing therapies

By Anthony Raphael
Apr 25, 2024 14:52 EST 2 Min read
The Ups and Downs of Lyfgenia: A Remarkable Gene Therapy for Sickle Cell Disease Medical Breakthroughs
The Ups and Downs of Lyfgenia: A Remarkable Gene Therapy for Sickle Cell Disease
By Medriva Correspondents
Jan 19, 2024 11:52 EST 2 Min read
The Rising Market for Genetic Medicines: Opportunities, Challenges and the Pricing Dilemma Medical Breakthroughs
The Rising Market for Genetic Medicines: Opportunities, Challenges and the Pricing Dilemma
By Medriva Correspondents
Jan 19, 2024 06:09 EST 3 Min read
Gene Therapies: A New Horizon in Medical Science Diseases
Gene Therapies: A New Horizon in Medical Science
By Anthony Raphael
Jan 18, 2024 04:28 EST 3 Min read
Groundbreaking CRISPR Gene-Editing Therapy Set to Transform Sickle Cell Treatment Medical Breakthroughs
Groundbreaking CRISPR Gene-Editing Therapy Set to Transform Sickle Cell Treatment
By Ethan Sulliva
Jan 18, 2024 04:16 EST 3 Min read
Groundbreaking Gene-Editing Treatment for Sickle Cell Disease: A Beacon of Hope Amidst Affordability Concerns Medical Breakthroughs
Groundbreaking Gene-Editing Treatment for Sickle Cell Disease: A Beacon of Hope Amidst Affordability Concerns
By Ethan Sulliva
Jan 18, 2024 02:54 EST 2 Min read
Insights from the Biotech Field: An Exclusive AMA Session with Adam Feuerstein Business
Insights from the Biotech Field: An Exclusive AMA Session with Adam Feuerstein
By Ethan Sulliva
Jan 18, 2024 02:51 EST 2 Min read
Targeted Gene Therapy: A New Path to Transplantation for Sickle Cell Disease and β Thalassemia Patients Medical Breakthroughs
Targeted Gene Therapy: A New Path to Transplantation for Sickle Cell Disease and β Thalassemia Patients
By Mason Walker
Jan 18, 2024 02:21 EST 2 Min read
A Landmark Deal: Editas and Vertex Strike a Significant Agreement on CRISPR-Cas9 Gene Editing Technology Breaking News
A Landmark Deal: Editas and Vertex Strike a Significant Agreement on CRISPR-Cas9 Gene Editing Technology
By Ethan Sulliva
Jan 18, 2024 02:19 EST 2 Min read
CRISPR Technology: Revolutionizing Genomic Medicine and Beyond Medical Breakthroughs
CRISPR Technology: Revolutionizing Genomic Medicine and Beyond
By Dr. Jessica Nelson
Jan 18, 2024 01:51 EST 2 Min read
1 2 ... Next
Advertisment
Chat with Dr. Medriva !